Open App →
Back to News Feed
PR Newswire November 16, 2026 positive

Remedy Robotics Raises $62 Million Series B to Bring Life-Saving Cardiovascular Intervention to Patients Everywhere

AI / LLM
<p>Funding will support clinical trials, advancement toward FDA approval, and planned commercial deployment of the company's AI-enabled endovascular robotic platform and software suite SAN FRANCISCO, Nov. 16, 2026 /PRNewswire/ -- Remedy Robotics, Inc. ("Remedy"), a leading healthcare and...</p>
Read original article ↗

Related Articles

New high-speed train begins tests at THSRC depot

Taipei Times · November 17, 2026

Taiwan ranked for AI integration, enthusiasm

Taipei Times · November 17, 2026

Furloughed workers in Taiwan fall to 19-month low

Taipei Times · November 17, 2026